WinstonWınston
Cigna Corporation logo

Cigna Corporation

CI
45
Medical - Healthcare Plans · Healthcare
Price
$281.45
-2.37 (-0.84%)
Market Cap
$74.45B
Winston Score
45
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Share count falling — buybacks

22.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 341.0M (2021) → 265.9M (2025)

Cigna is a large American health insurance and health services company. It sells medical, dental, and pharmacy insurance plans to employers, governments, and individuals. Its biggest business unit is Evernorth, which manages pharmacy benefits and handles prescription drug costs for millions of people across the United States.

Cigna makes money by collecting insurance premiums and fees for managing health benefits on behalf of large employers and other clients. It operates mainly in the United States but also has some international health benefits businesses. Its scale and long-term contracts with large employers give it a degree of stability, though its thin margins — common in managed care — mean small cost increases can quickly hurt profits. The key risk Cigna faces is rising medical costs, since the company must pay out claims when healthcare expenses climb faster than the premiums it collects.

Winston Score History

Politician Trades

30 trades / 12mo

11 Congressional buys and 19 sells on CI in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+4.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+29.1% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

0.5%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$7.0B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Cigna Corporation is growing revenue at 5% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
9.4%
Thin — 9.4% gross margin
Operating Margin
3.4%
Thin — 3.4% operating margin
ROCE
3.2%
Weak — 3.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+8.8%
Steady sales growth (8.8% YoY)
EPS YoY
+30.5%
Earnings growing fast (30.5% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
140%
Turns 140% of profit into real cash
FCF Margin
2.8%
Thin free cash flow (2.8%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.73
Moderate — manageable debt (0.73)
Interest Cover
6.92x
Adequate interest coverage (6.9x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
11.9x
Attractive valuation — P/E 11.9

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+4.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (11.9 → 7.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.18%
Moderate income — 2.18% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+5.5%
Dividend growing modestly (5.5% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial